Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC

NCT00000711 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Cytopenias

Interventions

DRUG: Zidovudine
DRUG: Sargramostim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)